Correlation Between Cameo Communications and Synmosa Biopharma

Can any of the company-specific risk be diversified away by investing in both Cameo Communications and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cameo Communications and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cameo Communications and Synmosa Biopharma, you can compare the effects of market volatilities on Cameo Communications and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cameo Communications with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cameo Communications and Synmosa Biopharma.

Diversification Opportunities for Cameo Communications and Synmosa Biopharma

0.0

Correlation Coefficient

Cameo Communications  Synmosa Biopharma

Pay attention - limited upside

The 3 months correlation between Cameo and Synmosa is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cameo Communications and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Cameo Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cameo Communications are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Cameo Communications i.e., Cameo Communications and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between Cameo Communications and Synmosa Biopharma

Assuming the 90 days trading horizon Cameo Communications is expected to under-perform the Synmosa Biopharma. In addition to that, Cameo Communications is 1.96 times more volatile than Synmosa Biopharma. It trades about -0.1 of its total potential returns per unit of risk. Synmosa Biopharma is currently generating about 0.05 per unit of volatility. If you would invest  3,360  in Synmosa Biopharma on December 23, 2024 and sell it today you would earn a total of  85.00  from holding Synmosa Biopharma or generate 2.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cameo Communications  vs.  Synmosa Biopharma

Cameo Communications

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cameo Communications has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Synmosa Biopharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Synmosa Biopharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Synmosa Biopharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Cameo Communications and Synmosa Biopharma

The main advantage of trading using opposite Cameo Communications and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cameo Communications position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.

The idea behind Cameo Communications and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.